| Overview |
| bsm-61822r-100ul |
| DCP1A Recombinant Antibody |
| WB, FCM, IHC-P, IHC-F, IF(IHC-P), IF(ICC) |
| Human, Mouse |
| Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| KLH conjugated synthetic peptide derived from human DCP1A |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target |
| 55802 |
| Q9NPI6 |
| Cytoplasm |
| Dcp1a; HSA275986; Nbla00360; SMAD4IP1; SMIF. |
| Necessary for the degradation of mRNAs, both in normal mRNA turnover and in nonsense-mediated mRNA decay.Removes the 7-methyl guanine cap structure from mRNA molecules, yielding a 5'-phosphorylated mRNA fragment and 7m-GDP.Contributes to the transactivation of target genes after stimulation by TGFB1. |
| Application Dilution |
| WB |
1:500-2000 |
| FCM |
FCM1:50-100 |
| IHC-P |
IHC-P1:50-200 |
| IHC-F |
IHC-F1:50-200 |
| IF(IHC-P) |
IFIHC-P1:50-200 |
| IF(ICC) |
IFICC1:50-200 |